Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310895
Status:
COMPLETED
Last Update Posted:
2015-12-24
First Post:
2006-04-04
Brief Title:
Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Sponsor:
Geron Corporation
Organization:
Geron Corporation
Organization Data
Organization:
Geron Corporation
Class:
INDUSTRY
Study ID:
GRN163L CP05-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Geron Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None